Related Experiment Video
Updated: Feb 7, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Extracellular Matrix-receptor Interaction Signaling Genes Associated with Inferior Breast Cancer Survival
Ming-Hsin Yeh1,2,3, Yau-Jin Tzeng4,5, Ting-Ying Fu6
1Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, R.O.C.
Background/Aim:
Breast cancer is a common type of cancer in women, and metastasis frequently leads to therapy failure. Using next-generation sequencing (NGS), we aspired to identify the optimal differentially expressed genes (DEGs) for use as prognostic biomarkers for breast cancer.
Materials And Methods:
NGS was used to determine transcriptome profiles in breast cancer tissues and their corresponding adjacent normal tissues from three patients with breast cancer.
Results:
Herein, 15 DEGs (fold change >4 and <0.25) involved in extracellular matrix (ECM)-receptor interaction signaling were identified through NGS. Among them, our data indicated that high HMMR expression levels were correlated with a poor pathological stage (p<0.001) and large tumor size (p<0.001), whereas high COL6A6 and Reelin (RELN) expression levels were significantly correlated with an early pathological stage (COL6A6: p=0.003 and RELN: p<0.001). Multivariate analysis revealed that high HMMR and SDC1 expression levels were significantly correlated with poor overall survival (OS; HMMR: adjusted hazard ratio [aHR] 1.93, 95% confidence interval [CI]=1.10-3.41, p=0.023; SDC1: [aHR] 2.47, 95%CI=1.28-4.77, p=0.007) for breast cancer. Combined, the effects of HMMR and SDC1 showed a significant correlation with poor OS for patients with breast cancer (high expression for both HMMR and SDC1: [aHR] 3.29, 95%CI=1.52-7.12, p=0.003).
Conclusion:
These findings suggest that HMMR and SDC1 involved in the ECM-receptor interaction signaling pathway could act as effective independent prognostic biomarkers for breast ductal carcinoma.
Insights
This study identified HMMR and SDC1 as key genes in breast cancer progression. High expression of these genes indicates a poorer prognosis, suggesting their potential as prognostic biomarkers.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Breast cancer is a prevalent malignancy in women, with metastasis often leading to treatment failure.
- Identifying reliable prognostic biomarkers is crucial for improving patient outcomes and therapeutic strategies.
Purpose of the Study:
- To identify optimal differentially expressed genes (DEGs) as prognostic biomarkers for breast cancer using next-generation sequencing (NGS).
- To investigate the correlation between gene expression and clinicopathological features and overall survival in breast cancer patients.
Main Methods:
- Transcriptome profiles of breast cancer tissues and adjacent normal tissues from three patients were analyzed using NGS.
- Differentially expressed genes (DEGs) were identified based on fold change, and their association with clinicopathological parameters and overall survival was evaluated.
Main Results:
- Fifteen DEGs involved in extracellular matrix (ECM)-receptor interaction signaling were identified.
- High HMMR expression correlated with poor pathological stage and larger tumor size.
- High COL6A6 and Reelin (RELN) expression correlated with early pathological stage.
- High HMMR and SDC1 expression levels were significantly associated with poor overall survival (OS).
- Combined high expression of HMMR and SDC1 showed a significant correlation with poor OS in breast cancer patients.
Conclusions:
- HMMR and SDC1, involved in the ECM-receptor interaction signaling pathway, show potential as effective independent prognostic biomarkers for breast ductal carcinoma.
- These genes could aid in predicting patient outcomes and guiding treatment decisions for breast cancer.
More Related Videos
Related Concept Videos
The Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Extracellular Matrix
Cancer Survival Analysis
Overview of Cell-Matrix Interactions
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....

